# Transcutaneous Vagal Nerve Stimulation to Prevent Tachyarrhythmias in Patients Early Following Myocardial Infarction

> **NCT05750108** · NA · UNKNOWN · sponsor: **Hippocration General Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Myocardial Infarction
- Tachyarrhythmia

## Interventions

- **DEVICE:** Parasym device (active, current (mA) < discomfort threshold)
- **DEVICE:** Parasym device (sham, current (mA) = 0)

## Key facts

- **NCT ID:** NCT05750108
- **Lead sponsor:** Hippocration General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06
- **Primary completion:** 2024-06
- **Final completion:** 2024-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05750108

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05750108, "Transcutaneous Vagal Nerve Stimulation to Prevent Tachyarrhythmias in Patients Early Following Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05750108. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*